FI  Tao Capital Partners

http://www.taocap.com/





     Office Locations:

311 S. Wacker Dr., Suite 4990
Chicago, IL 60606

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Education & Training
  • Energy & Clean Tech
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Real Estate & Construction
  • Software & Internet
  • Transportation & Distribution

  •  

    Description:

    Tao Ventures is an investment vehicle for Nicholas Pritzker and Joby Pritzker, heirs to the Pritzker family fortune. Tao Invest, the direct investment entity affiliated with Tao Capital Partners, invests in technology, alternative energy and transportation, healthcare, education, sustainable food & agriculture, consumer, and real estate businesses that have a positive impact. Tao is an active investor with the ability to support companies through various stages of their life-cycle.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Christopher Olin Partner
    Isaac Pritzker Director
    Joby Pritzker Co-Founder
    Matt Bigliardi Director of Investments
    Nicholas Pritzker Co-Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/05/2024


      AMP Robotics


      CO


      $91,000,000


      Series D


      08/15/2024


      Quantum Circuits Inc


      CT


      $60,000,000


      Series B


      07/17/2024


      Truvian


      CA


      $74,000,000


      


      06/24/2024


      Iambic Therapeutics


      CA


      $50,000,000


      Series B Extension


     

    Portfolio companies include:


      100 Thieves
        web link


      908 Devices
        web link


      Activ Surgical
        web link


      AMP
        web link


      AMP Robotics
        web link


      Apeel Sciences
        web link


      Apnimed
        web link


      BitTitan
        web link


      DreamBox Learning
        web link


      Elephas Biosciences
        web link


      enlighted
        web link


      Good Eggs
        web link


      Greenlight Biosciences


      Hazel Health
        web link


      Holo
        web link


      Iambic Therapeutics
        web link


      Kingdom Supercultures
        web link


      MJ Freeway
        web link


      Newsela
        web link


      Ouster


      Pax Labs
        web link


      Powerhive
        web link


      ProctorFree


      Proterra


      Quantum Circuits Inc
        web link


      Raken
        web link


      RapidDeploy


      Revinate
        web link


      Ripple Foods


      SKUPOS
        web link


      Sonder


      Soylent
        web link


      TemperPack


      Truvian
        web link


      Verge Genomics
        web link


      Vizgen


      Zymergen


     

    Recent News: